Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster I
    Location: Hall F1
     CE: 0.00
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0337: Bridging the Bone Gap: A Quality Improvement Project on Osteoporosis Screening Practices in a Teaching Institution
    Location: Hall F1
    Abstract Poster Presenter: Aakanksha Pitliya, MD (she/her/hers) – Mercy Catholic Medical Center, Darby, PA
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0338: Fractures and Changes in Bone Mineral Density During Two Years of Low Dose Glucocorticoid Treatment for Rheumatoid Arthritis: A Systematic Literature Review and Individual Participant Data Meta-Analysis
    Location: Hall F1
    Abstract Poster Presenter: Andriko Palmowski, MD – Charité - Universitätsmedizin Berlin
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0339: Evaluating Discordance between Bilateral Hip Bone Density Measurements in Individuals with Low Bone Mass
    Location: Hall F1
    Abstract Poster Presenter: Anupama Shahane, MD, MPH – University of Pennsylvania
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0340: Associations with fragility fractures in a population with inflammatory bowel disease (IBD): An observational study.
    Location: Hall F1
    Abstract Poster Presenter: Chern Lee Choy, MBBS – University Hospitals of Morecambe Bay NHS Foundation Trust
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0341: Romosozumab in patients with Osteoporosis: Safety and Efficacy analysis in Clinical Practice
    Location: Hall F1
    Abstract Poster Presenter: Daniel Ramos Castro, MD – Hospital Universitari i Politecnic La Fe
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0342: Comparison of Cortical Backscatter Ultrasound, Reference-Point Indentation and Bone Mineral Density in Discriminating Prevalent Fragility Fractures in Inflammatory Rheumatic Diseases: A Pilot Study
    Location: Hall F1
    Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0343: Impact of Janus Kinase Inhibitors on Bone Mineral Density and Microarchitecture in Rheumatoid and Psoriatic Arthritis: Insights from a Real-World Cohort
    Location: Hall F1
    Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0344: Inpatient Zoledronic Acid for Glucocorticoid-Induced Osteoporosis Prevention
    Location: Hall F1
    Abstract Poster Presenter: Gregory Challener, MD – Massachusetts General Hospital
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0345: Association Between Deprivation and Fracture Risk in a Regional UK Cohort
    Location: Hall F1
    Abstract Poster Presenter: Hashem Cheema, MBBS BSc MRCP – University Hospitals of Morecambe bay NHS foundation trust
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0346: Fibroblast Growth Factor-23 and Bone Status in Patients with Chronic Kidney Disease Compared to a Healthy Control Group and Its Relationship with Cardiovascular Risk
    Location: Hall F1
    Abstract Poster Presenter: José Rodríguez Gago, Sr, MD – Hospital Universitario La Paz
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0347: Identifying Risk Factors for Fragility Fractures in Patients with Coeliac Disease: An Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Kabyar Cho, MBChB, BSc – University Hospitals of Morecambe Bay NHS Foundation Trust
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0348: Correlation between Bone Mineral Density by Dual-energy X-ray Absorptiometry at the Radius and Radius Cortical Bone Thickness using Routine Hand Radiographs in Rheumatoid Arthritis Patients
    Location: Hall F1
    Abstract Poster Presenter: Karla Miller, MD (she/her/hers) – University of Utah School of Medicine
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0349: Underrecognized Glucocorticoid-Induced Osteoporosis in a Polymyalgia Rheumatica Patient Cohort
    Location: Hall F1
    Abstract Poster Presenter: Katherine Loomba, DO – Dartmouth Hitchcock Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0350: Perioperative Evaluation of Blood Tests Including Bone Turnover Markers in Patients Undergoing Surgery for Proximal Femur Fractures
    Location: Hall F1
    Abstract Poster Presenter: KEN NAKASEKO, MD, PhD – Department of Orthopaedic Surgery and Rheumatology, Kuwana City Medical Center
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0351: Experience with romosozumab in women with osteoporosis at high risk of fracture in real-world clinical practice
    Location: Hall F1
    Abstract Poster Presenter: MARIA DEL CARMEN ORTEGA DE LA O, Sr, MBBS (she/her/hers) – HOSPITAL UNIVERSITARIO GETAFE
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0352: Complication Rates of Typical Hip Fractures, Subtrochanteric Femoral Fractures, and Atypical Femoral Fractures
    Location: Hall F1
    Abstract Poster Presenter: Marshall Weber, MD – Augusta University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0353: Incidence of Clinical Fragility Fractures and Mortality in Patients with Rheumatoid Arthritis Treated with Rituximab
    Location: Hall F1
    Abstract Poster Presenter: Montserrat Roig-Kim, MD – Hospital Universitari de Bellvitge
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0354: Greater Neighborhood Walkability is Associated with Lower Incidence of Hip Fracture in Older, Community-dwelling Women in the United States: The Cardiovascular Health Study
    Location: Hall F1
    Abstract Poster Presenter: Rachel Elam, MD, MS (she/her/hers) – Augusta University
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0355: Changes in scanographic bone mineral density in melanoma patients treated with immunotherapy
    Location: Hall F1
    Abstract Poster Presenter: Soukayna BADDI, DM – Academy Of Caen
  • Sunday, Oct 26th
    10:30 AM - 12:30 PM Central Time
    0356: An Analysis of Osteoporosis Screening in Males 50 and Older with Rheumatic Disease Across Stony Brook Medicine Network
    Location: Hall F1
    Abstract Poster Presenter: Stephen Poos, DO – Stony Brook Medicine
  • Monday, Oct 27th
    4:15 PM - 5:15 PM Central Time
    27M76: Sticks and Stones: Cellular and Molecular Mechanisms of Inflammatory Bone Loss
    Location: W181A-C
    Moderator: Mary Beth Humphrey, MD, PhD – University of Oklahoma College of Medicine
    Moderator: Baohong Zhao, MD, PhD – Hospital for Special Surgery
    Session Coordinator: Baohong Zhao, MD, PhD – Hospital for Special Surgery
     CE: 1.00
  • Monday, Oct 27th
    4:15 PM - 4:45 PM Central Time
    Macrophages, Osteoclast Origin and Bone Remodeling/repair
    Location: W181A-C
    Speaker: Benjamin Alman, MD – Duke University
  • Monday, Oct 27th
    4:45 PM - 5:15 PM Central Time
    DNA Hypomethylation, IRF8, and Inflammatory Arthritis
    Location: W181A-C
    Speaker: Yousef Abu-Amer, PhD, MSc – Washington University in St Louis
  • Tuesday, Oct 28th
    8:30 AM - 9:30 AM Central Time
    28T10: Updates in Osteoporosis: Where They 'Fall Short'
    Location: W196A-C
    Moderator: Maria I. ("Maio") Danila, MD, MSc, MPH – University of Alabama at Birmingham (UAB), Birmingham VA Medical Center
    Moderator: Nancy Lane, MD, BA – University of California at Davis, School of Medicine
    Session Coordinator: Lesley Jackson, MD, MSPH – University of Alabama at Birmingham
    Session Coordinator: Nancy Lane, MD, BA – University of California at Davis, School of Medicine
     CE: 1.00
  • Tuesday, Oct 28th
    8:30 AM - 9:00 AM Central Time
    Identify and Stratify Osteoporosis Risk Using Current Diagnostic Tools
    Location: W196A-C
    Speaker: Elaine Yu, MD, MMSc – Harvard Medical School
  • Tuesday, Oct 28th
    9:00 AM - 9:30 AM Central Time
    Apply Updated Clinical Guidelines to Manage Osteoporosis in Special Patient Populations
    Location: W196A-C
    Speaker: Sharon M. Moe, MD – Indiana University
  • Tuesday, Oct 28th
    10:00 AM - 11:30 AM Central Time
    28T24: Women Have a Bone to Pick: Hormonal Regulation of Osteoporosis
    Location: W475A-B
    Moderator: Julia Charles, MD, PhD – Department of Orthopedic Surgery & Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital
    Moderator: Baohong Zhao, MD, PhD – Hospital for Special Surgery
    Session Coordinator: Baohong Zhao, MD, PhD – Hospital for Special Surgery
     CE: 1.50
  • Tuesday, Oct 28th
    10:00 AM - 10:30 AM Central Time
    A Maternal Brain Hormone Builds Bone
    Location: W475A-B
    Speaker: Thomas H Ambrosi, PhD – UC Davis Health
  • Tuesday, Oct 28th
    10:30 AM - 11:00 AM Central Time
    Menopause-Induced Loss of 17β-Estradiol and Progesterone Regulates Cartilage Senescence and Degeneration
    Location: W475A-B
    Speaker: Fabrisia Ambrosio, PhD – Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute at Spaulding, Boston, MA, USA.
  • Tuesday, Oct 28th
    11:00 AM - 11:30 AM Central Time
    Effects of Intermittent Senolytic Therapy on Bone Metabolism in Postmenopausal Women
    Location: W475A-B
    Speaker: Sundeep Khosla, MD – Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN, USA.
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster II
    Location: Hall F1
     CE: 0.00
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2106: Prevalence and Characteristics of Morphometric Vertebral Fractures in the Spanish Population: Data from the OsteoSER Study
    Location: Hall F1
    Abstract Poster Presenter: Carmen Gomez Vaquero, MD – Hospital Universitari de Bellvitge
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2107: Experience of a Fragility Fracture Coordination Unit Integrated Across Two Hospitals: An Innovative Multidisciplinary Model for Optimizing the Management of Geriatric and Non-Geriatric Patients Beyond Surgery After an Osteoporotic Bone Fragility Fracture
    Location: Hall F1
    Abstract Poster Presenter: César Antonio Egües Dubuc, MD,MSc (he/him/his) – Hospital Universitario Donostia
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2108: Multidisciplinary Fragility Fracture Management Across Two Coordinated Hospitals: Evaluating Risk Factors, Treatment Approaches, and Long-Term Patient Outcomes in Those With and Without Prior Fractures
    Location: Hall F1
    Abstract Poster Presenter: César Antonio Egües Dubuc, MD,MSc (he/him/his) – Hospital Universitario Donostia
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2109: Comparative Effects of IL-6 inhibition, Methotrexate, and Glucocorticoid Monotherapy on Bone Mineral Density, 3D-DXA femoral structure and Bone Turnover Markers in GCA and PMR
    Location: Hall F1
    Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2110: Effect of Proton-Pump-Inhibitors on Bone Mineral Density and Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases
    Location: Hall F1
    Abstract Poster Presenter: Edgar Wiebe, MD – Charité University Medicine Berlin
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2111: Cost-effectiveness Analysis of Biosimilar Denosumab for the Treatment of Women with Post-menopausal Osteoporosis in the United States: A Risk Based Analysis
    Location: Hall F1
    Abstract Poster Presenter: Edward Li, PharmD, MPH (he/him/his) – Sandoz Inc.
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2112: Which drugs are associated with the development of osteonecrosis of the jaw? clinical and epidemiological analysis of a cohort of patients diagnosed with osteonecrosis of the jaw.
    Location: Hall F1
    Abstract Poster Presenter: Esther Monleon Acosta, -None- – Hospital Santa Lucia
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2113: Mortality rate in patients with hip fracture: is it recommendable to establish fracture units?
    Location: Hall F1
    Abstract Poster Presenter: Esther Monleon Acosta, -None- – Hospital Santa Lucia
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2114: Development of a Fracture Prediction Model for Patients Aging with HIV
    Location: Hall F1
    Abstract Poster Presenter: Evelyn Hsieh, MD, PhD (she/her/hers) – Yale School of Medicine/VA Connecticut Healthcare Center
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2115: METHOFRACT, a methotrexate osteopathy multicentric binational cohort study.
    Location: Hall F1
    Abstract Poster Presenter: François ROBIN, MD, PhD (he/him/his) – Rennes University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2116: Romosozumab in Multiple Myeloma Patients at High Risk of Fracture
    Location: Hall F1
    Abstract Poster Presenter: Giovanni Adami, MD – University of Verona, Italy
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2117: Denosumab Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis: A Multi-site Randomized Clinical Trial
    Location: Hall F1
    Abstract Poster Presenter: Giovanni Adami, MD – University of Verona, Italy
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2118: Risks of Fracture in Current and Previous Anticonvulsant Users, An Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Grace Hyeyeon Lee, MBBS – Newcastle University
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2119: Fracture rates in 6475 individuals with osteogenesis imperfecta stratified by age, sex and clinical severity
    Location: Hall F1
    Abstract Poster Presenter: Jeffrey Curtis, MD, MS, MPH – University of Alabama at Birmingham
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2120: Analyzing Gender and Racial Disparities in Paget’s Disease of Bone: A Large-scale Observational Study
    Location: Hall F1
    Abstract Poster Presenter: Kinga Grzybowski, MD – Jefferson Einstein Montgomery Hospital
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2121: Prevention of Bone Mass Loss Associated With Aromatase Inhibitors in Breast Cancer. A Study in Real-World Clinical Practice.
    Location: Hall F1
    Abstract Poster Presenter: Lucia Paz Liñeira, -None- – Hospital General Universitario Gregorio Marañón
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2122: Safety and Efficacy of Romosozumab in the Treatment of Patients with High-Risk Fracture Osteoporosis in Clinical Practice: Experience from a Tertiary University Hospital in Spain
    Location: Hall F1
    Abstract Poster Presenter: Maryia Nikitsina, DM (she/her/hers) – University Hospital la Princesa, Madrid
  • Tuesday, Oct 28th
    10:30 AM - 12:30 PM Central Time
    2123: Sclerostin in Aging Bone and Muscle: A Comparative Study of Osteoporosis, Sarcopenia, and Osteosarcopenia
    Location: Hall F1
    Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD, PhD, FACR (he/him/his) – Faculty of Medicine, Cairo University
  • Tuesday, Oct 28th
    1:00 PM - 2:30 PM Central Time
    28T32: Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science
    Location: W192A-C
    Abstract Moderator: Carter Thorne, MD, FRCPC, FACP, FACR, MACR – Southlake Regional Health Centre
    Abstract Moderator: Sonali Khandelwal, MD – Rush University
     CE: 0.00
  • Tuesday, Oct 28th
    1:00 PM - 1:15 PM Central Time
    2591: Association Between Changes in Bone Quality Parameters and Inflammatory Ratios in Postmenopausal Women Treated with Romosozumab: A Retrospective Observational Study
    Location: W192A-C
    Presenting Author: Montserrat Robustillo Villarino, MD, PhD, MSc (she/her/hers) – Conselleria de Sanitat Valenciana
  • Tuesday, Oct 28th
    1:15 PM - 1:30 PM Central Time
    2592: Romosozumab and Denosumab Combination Therapy in Postmenopausal Osteoporosis
    Location: W192A-C
    Presenting Author: Giovanni Adami, MD – University of Verona, Italy
  • Tuesday, Oct 28th
    1:30 PM - 1:45 PM Central Time
    2593: Single Switch from Reference Denosumab to TVB-009 in Women with Postmenopausal Osteoporosis: Analysis of the Phase 3, Randomized, Double-Blind, Multinational, Multicenter Study
    Location: W192A-C
    Presenting Author: Anton Buchner, PhD – Teva Pharmaceuticals
  • Tuesday, Oct 28th
    1:45 PM - 2:00 PM Central Time
    2594: Comparing Immunogenicity Between TVB-009 and Reference Denosumab in Healthy Adults and Participants with Postmenopausal Osteoporosis
    Location: W192A-C
    Presenting Author: Bracha Timan, PhD, MBA – Teva Pharmaceuticals Ind Ltd
  • Tuesday, Oct 28th
    2:00 PM - 2:15 PM Central Time
    2595: Impact of Different Types of Physical Activity on Bone Health in Patients with Inflammatory Rheumatic Diseases: a Cross-Sectional Analysis from a Prospective Cohort Study
    Location: W192A-C
    Presenting Author: Edgar Wiebe, MD – Charité University Medicine Berlin
  • Tuesday, Oct 28th
    2:15 PM - 2:30 PM Central Time
    2596: Predicting Osteoporosis Using Routine Clinical Data: A Machine Learning Approach
    Location: W192A-C
    Presenting Author: Shiza Sarfraz, MD – Brody School of Medicine